Advocacy Actions
MIIT seminar on RoHS, COCIR is one of the supporting organizations and gave presentation
RoHS seminar organized by MIIT, COCIR is one of the supporting organizations and presented on exemption procedure.
Read moreSubmit Comments to CFDA on On-Site Inspections of Clinical Trials for Medical Devices
The CFDA has published three regulations regarding On-Site Inspections of Clinical Trials for Medical Devices for public consultation, thereof two for the second round of consultation.
The European Chamber submitted consolidated comments on behalf of their members.
Meeting with DDG of Anhui Department of Commerce
European Chamber Shanghai Pharmaceutical Working Group delegation met with DDG of Anhui Department of Commerce
Read moreMeeting with Anhui Health and Family Planning Commission and Medicine Procurement Center
European Chamber Shanghai Pharmaceutical Working Group delegation met with DDG of Anhui Department of Commerce and Deputy Director of Medicine Procurement Center
Read moreMeeting with Deputy Director General Gao Qing, Jiangsu Provincial Commission of Economy and Information Technology (JSCEIT)
On Thursday 26th May 2016, Mr. Bernhard Weber, the Chair of European Chamber Nanjing Board met with Mr. Gao Qing, the Deputy Director-General of JSCEIT. During the meeting, Mr. Weber presented the report of Overcapacity in China to Mr. Gao and discussed the European Chamber’s concerns on overcapacities in China.
Read moreExclusive Dialogue with NDRC on Negative List
On 25 May 2016, an Exclusive Dialogue with Deputy Director General Gelong Song from the Department of Economic System Reform of the NDRC was held.
Read moreMeet with the Basel Convention Coordinating Centre for Asia and the Pacific
COCIR China Environmental Focus Group experts visit Basel Convention Coordinating Centre, explaining DITTA position on technical guidance of the Basel Convention
Read moreChina Outlook: 13th Five-Year-Plan
In March 2016, the Chinese Central Government officially released the 13th Five-Year-Plan (FYP). This 13th FYP is China’s master policy blueprint in which the highest levels of the Chinese leadership set out the goals, principles and targets for China’s development in the next five years. Furthermore, it provides orientation for China’s economic and social development and points out the challenges and objectives on deepening reforms and strategies to welcome the “new era” of the Chinese economy. As this will have a significant impact not only on China, but also on the rest of the world, investors should have a closer look at the changes and new reforms to adjust their business operations accordingly.
Read moreComments on CFDA's Draft “Regulatory Guideline on Cold Chain (Transport, Storage) of Medical Devices”
On 06 May, the CFDA has initiated a Public Consultation on the Draft “Regulatory Guideline on Cold Chain (Transport, Storage) of Medical Devices”. In reply, the European Chamber has submitted consolidated comments on this draft regulation.
Read moreMeeting with Shanghai Development Reform Commission DDG on Shanghai FTZ
European Chamber Vice President met with Shanghai Development Reform Commission DDG Mr. ZHU Min on latest development of Shanghai FTZ
Read more